Week Ending May 10, 2021

Ending cancer as we know it? National Cancer Institute Director Ned Sharpless lays out his vision.
“President Biden, whose son Beau died of a brain tumor, has promised to “end cancer as we know it.” To better understand how that could happen, USA TODAY spoke with Ned Sharpless, director of the National Cancer Institute, which will help lead the effort.”

AstraZeneca’s Tremelimumab Offers Survival Benefit With IMFINZI in Advanced Lung Cancer
“A final analysis of AstraZeneca’s Phase III POSEIDON trial shows IMFINZI (durvalumab), the company’s human monoclonal antibody and cancer immunotherapy, offered improvements in overall survival (OS) when added to tremelimumab and chemotherapy versus chemotherapy alone in patients with Stage IV (metastatic) non-small cell lung cancer (NSCLC).”

Patient With RET-Mutated Lung Cancer Is Eligible for Therapy With Selpercatinib or Pralsetinib
“Luis Raez, MD, Hematology & Oncology medical director and chief scientific officer, Memorial Cancer Institute, Memorial Healthcare System, discussed the case of a 59-year-old patient with RET-mutated lung cancer.”

What to Know About Telehealth for Lung Cancer
“Telehealth refers to the use of telecommunications technology to provide health care from a distance. It started out with programs which connected patients to nurses over the phone. Telehealth has evolved over the years, and healthcare providers now make use of videoconferencing, mobile health apps, emails, and secure texts to deliver care to their patients.”

The Different Roads of Lung Cancer
“We all handle things differently, look at things differently and understand differently, meaning that the journey of each patient with cancer is unique. But there are always similarities among the symptoms, risks and treatments.”